These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17244165

  • 1. Heart rate variability is related to pain severity and predominant bowel pattern in women with irritable bowel syndrome.
    Cain KC, Jarrett ME, Burr RL, Hertig VL, Heitkemper MM.
    Neurogastroenterol Motil; 2007 Feb; 19(2):110-8. PubMed ID: 17244165
    [Abstract] [Full Text] [Related]

  • 2. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
    Cain KC, Headstrom P, Jarrett ME, Motzer SA, Park H, Burr RL, Surawicz CM, Heitkemper MM.
    Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
    [Abstract] [Full Text] [Related]

  • 3. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A, Houghton LA, Lea R, Morris J, Reilly B, Whorwell PJ.
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [Abstract] [Full Text] [Related]

  • 4. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ.
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [Abstract] [Full Text] [Related]

  • 5. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses.
    Elsenbruch S, Orr WC.
    Am J Gastroenterol; 2001 Feb; 96(2):460-6. PubMed ID: 11232691
    [Abstract] [Full Text] [Related]

  • 6. Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients.
    Mazur M, Furgała A, Jabłoński K, Madroszkiewicz D, Ciećko-Michalska I, Bugajski A, Thor PJ.
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():131-9. PubMed ID: 17901589
    [Abstract] [Full Text] [Related]

  • 7. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [Abstract] [Full Text] [Related]

  • 8. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?
    Sach J, Bolus R, Fitzgerald L, Naliboff BD, Chang L, Mayer EA.
    Am J Gastroenterol; 2002 Dec; 97(12):3131-8. PubMed ID: 12492200
    [Abstract] [Full Text] [Related]

  • 9. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
    [Abstract] [Full Text] [Related]

  • 10. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
    Gonlachanvit S, Mahayosnond A, Kullavanijaya P.
    Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
    [Abstract] [Full Text] [Related]

  • 11. [Autonomic nervous system activity in IBS patients estimated by heart rate variability (HRV)].
    Dobrek Ł, Friediger J, Furgała A, Thor PJ.
    Przegl Lek; 2006 Jan; 63(9):743-7. PubMed ID: 17479861
    [Abstract] [Full Text] [Related]

  • 12. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

  • 13. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA.
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [Abstract] [Full Text] [Related]

  • 14. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
    Király A, Csizmadia C, Illés A, Undi S.
    Orv Hetil; 2006 Mar 05; 147(9):421-6. PubMed ID: 16619961
    [Abstract] [Full Text] [Related]

  • 15. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL, Cain KC, Jarrett ME, Burr RL, Heitkemper MM.
    Nurs Res; 2007 Mar 05; 56(6):399-406. PubMed ID: 18004186
    [Abstract] [Full Text] [Related]

  • 16. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.
    Kuiken SD, Lindeboom R, Tytgat GN, Boeckxstaens GE.
    Aliment Pharmacol Ther; 2005 Jul 15; 22(2):157-64. PubMed ID: 16011674
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F, Badía X, Balboa A, Benavent J, Caballero AM, Domínguez-Muñoz E, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M, RITMO Group.
    Aliment Pharmacol Ther; 2006 Mar 15; 23(6):815-26. PubMed ID: 16556184
    [Abstract] [Full Text] [Related]

  • 18. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
    [Abstract] [Full Text] [Related]

  • 19. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
    Garrigues V, Mearin F, Badía X, Balboa A, Benavent J, Caballero A, Domínguez E, Díaz-Rubio M, Roset M, Figueras M, Cucala M, RITMO GROUP.
    Aliment Pharmacol Ther; 2007 Feb 01; 25(3):323-32. PubMed ID: 17217445
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 01; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.